These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Rhino-orbito-cerebral mucormycosis: patient characteristics in pre-COVID-19 and COVID-19 period. Cherian LM; Varghese L; Rupa V; Bright RR; Abraham L; Panicker R; R N; Peter J; Nayak A; Shyam A; Varghese GM; Manesh A; Karuppusami R; George K; George T; Lenin A; Hansdak SG; I R; Michael JS; Ninan M; Thomas M; Kurian R; Mammen S; Kurien R Rhinology; 2022 Dec; 60(6):427-434. PubMed ID: 36150158 [TBL] [Abstract][Full Text] [Related]
23. Rhino-orbito-cerebral mucormycosis. Management strategies to avoid or limit intracraneal affection and improve survival. Plowes Hernández O; Prado Calleros HM; Soberón Marmissolle Daguerre GS; Sadek González A Acta Otorrinolaringol Esp; 2015; 66(6):348-52. PubMed ID: 26048708 [TBL] [Abstract][Full Text] [Related]
24. Exudative retinal detachment in COVID-19 - associated rhino-orbital mucormycosis - A rare clinical finding. Sarkar S; Gokhale T; Kaliaperumal S; Singh R; Begam RB; Deb AK Indian J Ophthalmol; 2021 Sep; 69(9):2535-2537. PubMed ID: 34427262 [TBL] [Abstract][Full Text] [Related]
25. Early suspicion can save lives; mucormycosis in two children with diabetic ketoacidosis in Pakistan. Shahid A; Fatima B; Khan YN; Ibrahim MN; Raza J J Pak Med Assoc; 2022 Apr; 72(4):790-792. PubMed ID: 35614628 [TBL] [Abstract][Full Text] [Related]
26. Bilateral ophthalmic artery occlusion in rhino-orbito-cerebral mucormycosis. Song YM; Shin SY Korean J Ophthalmol; 2008 Mar; 22(1):66-9. PubMed ID: 18323710 [TBL] [Abstract][Full Text] [Related]
27. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients. Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124 [TBL] [Abstract][Full Text] [Related]
28. First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus. Diwakar J; Samaddar A; Konar SK; Bhat MD; Manuel E; Hb V; Bn N; Parveen A; Hajira SN; Srinivas D; S N J Mycol Med; 2021 Dec; 31(4):101203. PubMed ID: 34517273 [TBL] [Abstract][Full Text] [Related]
29. Outcomes and factors affecting them in patients with rhino-orbito-cerebral mucormycosis. Kashkouli MB; Abdolalizadeh P; Oghazian M; Hadi Y; Karimi N; Ghazizadeh M Br J Ophthalmol; 2019 Oct; 103(10):1460-1465. PubMed ID: 30514712 [TBL] [Abstract][Full Text] [Related]
30. Increased serum ferritin is associated with severity of orbital disease in COVID-19-associated rhino-orbito-cerebral mucormycosis: A quantitative analysis. Tanwar S; Mishra N; Sharma P; Kaur A Indian J Ophthalmol; 2024 Jul; ():. PubMed ID: 38990622 [TBL] [Abstract][Full Text] [Related]
31. Facial Nerve Palsy: An Unusual Presentation in Patients with Rhino Cerebral Mucormycosis. Mane R; Patil B; Mohite A; Mohanty R Indian J Otolaryngol Head Neck Surg; 2019 Nov; 71(Suppl 3):2110-2113. PubMed ID: 31763303 [TBL] [Abstract][Full Text] [Related]
34. Rhino-orbito-cerebral mucormycosis during the COVID-19 third wave in 2021: an Egyptian preliminary report from a single tertiary hospital. Alloush TK; Mansour O; Alloush AT; Roushdy T; Hamid E; El-Shamy M; Shokri HM Neurol Sci; 2022 Feb; 43(2):799-809. PubMed ID: 34787754 [TBL] [Abstract][Full Text] [Related]
35. [Rhino-orbito-cerebral mucormycosis, surgical treatment, state of the art]. Vironneau P; Verillaud B; Tran H; Altabaa K; Blancal JP; Sauvaget E; Herman P; Kania R Med Sci (Paris); 2013 Mar; 29 Spec No 1():31-5. PubMed ID: 23510523 [TBL] [Abstract][Full Text] [Related]
36. Survival after rhino-orbital-cerebral mucormycosis in an immunocompetent patient. Fairley C; Sullivan TJ; Bartley P; Allworth T; Lewandowski R Ophthalmology; 2000 Mar; 107(3):555-8. PubMed ID: 10711895 [TBL] [Abstract][Full Text] [Related]
37. Rhino-orbito-cerebral mucormycosis: a treatment dilemma. Jeevanan J; Gendeh BS; Faridah HA; Vikneswaran T Med J Malaysia; 2006 Mar; 61(1):106-8. PubMed ID: 16708746 [TBL] [Abstract][Full Text] [Related]
38. Anterior Cavernous and Internal Carotid Artery Thrombosis - A Rare Complication of Rhino-orbito-cerebral Mucormycosis. Juneja A; Anand KS; Bhowmik S; Mahajan R; Dubey M Neurol India; 2021; 69(6):1876-1877. PubMed ID: 34979719 [No Abstract] [Full Text] [Related]
39. Fatal rhino-orbito-cerebral mucormycosis in an apparently normal host: case report and literature review. Sharma RR; Pawar SJ; Delmendo A; Lad SD; Athale SD J Clin Neurosci; 2001 Nov; 8(6):583-6. PubMed ID: 11683615 [TBL] [Abstract][Full Text] [Related]
40. Immunosuppression is a Double-Edged Sword in COVID-19 Treatment: a Case Report of Rhino-Orbito-Cerebral Mucormycosis. Sedaghattalab M; Bagheri T; Doustimotlagh AH Clin Lab; 2022 Jul; 68(7):. PubMed ID: 35975535 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]